Status:
COMPLETED
Advance Care Planning in the Emergency Department
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Congestive Heart Failure
Metastatic Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a two-armed, parallel-design, pre-/post-intervention assessment study. The investigators will conduct a randomized controlled trial for ED GOAL on a cohort of 120 older adults with serious ill...
Detailed Description
ED GOAL, a 6-minute motivational interview conducted in the emergency department (ED), which engages participants to address advance care planning (ACP) conversations with their outpatient clinicians ...
Eligibility Criteria
Inclusion
- ≥50 years of age AND ≥1 Serious illness\* OR ED clinician would not be surprised if patient died in the next 12 months (a validated prognostic sign)
- English-speaking
- Capacity to consent
- Patient with mild cognitive impairment or mild dementia with capacity to consent (requires a caregiver/study partner to enroll)
- Caregiver of patient with moderate/severe dementia with capacity to consent
- (\*) NYHA Stage III/IV congestive heart failure, chronic obstructive lung disease on home oxygen, chronic kidney disease on dialysis, or metastatic solid tumor cancer. In addition, patients with NYHA Stage I/II congestive heart failure, chronic obstructive lung disease not on home oxygen, chronic kidney disease not on dialysis will be included if recent hospitalization in the last 12 months exists.
Exclusion
- Acute physical or emotional distress
- Determined by treating or study clinician not to be appropriate
- Clearly documented goals for medical care\*\* (Unless the treating or study clinician recommends that the intervention is clinically indicated)
- Delirium (assessed using 3D-CAM)
- Already enrolled in this study
- Unable/unwilling to schedule the follow-ups on the calendar
- Receive both the outpatient care for serious illness and primary care outside of the Mass General Brigham health system
- (\*\*)e.g., MOLST, medical order for life-sustaining treatment, documented serious illness conversations in clinician notes within the last 3 months, etc.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT05209880
Start Date
March 1 2022
End Date
July 1 2024
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115